Characterisation of the Toxoplasma gondii tyrosine transporter and its phosphorylation by the calcium-dependent protein kinase 3.


Journal

Molecular microbiology
ISSN: 1365-2958
Titre abrégé: Mol Microbiol
Pays: England
ID NLM: 8712028

Informations de publication

Date de publication:
05 2019
Historique:
accepted: 20 10 2018
pubmed: 8 11 2018
medline: 31 1 2020
entrez: 8 11 2018
Statut: ppublish

Résumé

Toxoplasma gondii parasites rapidly exit their host cell when exposed to calcium ionophores. Calcium-dependent protein kinase 3 (TgCDPK3) was previously identified as a key mediator in this process, as TgCDPK3 knockout (∆cdpk3) parasites fail to egress in a timely manner. Phosphoproteomic analysis comparing WT with ∆cdpk3 parasites revealed changes in the TgCDPK3-dependent phosphoproteome that included proteins important for regulating motility, but also metabolic enzymes, indicating that TgCDPK3 controls processes beyond egress. Here we have investigated a predicted direct target of TgCDPK3, ApiAT5-3, a putative transporter of the major facilitator superfamily, and show that it is rapidly phosphorylated at serine 56 after induction of calcium signalling. Conditional knockout of apiAT5-3 results in transcriptional upregulation of most ribosomal subunits, but no alternative transporters, and subsequent parasite death. Mutating the S56 to a non-phosphorylatable alanine leads to a fitness cost, suggesting that phosphorylation of this residue is beneficial, albeit not essential, for tyrosine import. Using a combination of metabolomics and heterologous expression, we confirmed a primary role in tyrosine import for ApiAT5-3. However, no significant differences in tyrosine import could be detected in phosphorylation site mutants showing that if tyrosine transport is affected by S56 phosphorylation, its regulatory role is subtle.

Identifiants

pubmed: 30402958
doi: 10.1111/mmi.14156
pmc: PMC6488386
mid: NIHMS994388
doi:

Substances chimiques

Calcium-Binding Proteins 0
Protozoan Proteins 0
Tyrosine 42HK56048U
Protein Kinases EC 2.7.-
calcium-dependent protein kinase EC 2.7.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1167-1181

Subventions

Organisme : Wellcome Trust
ID : 204809
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI123457
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001189
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001189
Pays : United Kingdom

Informations de copyright

© 2018 The Authors. Molecular Microbiology Published by John Wiley & Sons Ltd.

Références

J Plant Physiol. 2014 Sep 15;171(15):1401-12
pubmed: 25046761
Biochemistry. 1996 Oct 8;35(40):13222-30
pubmed: 8855961
Proteins. 2011 Mar;79(3):803-20
pubmed: 21287613
Cell Microbiol. 2017 Apr;19(4):
pubmed: 27781359
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15959-64
pubmed: 17898163
Mol Cell Biol. 2000 Dec;20(24):9399-408
pubmed: 11094090
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Proc Natl Acad Sci U S A. 2014 May 13;111(19):7132-7
pubmed: 24778259
Infect Immun. 2016 Apr 22;84(5):1262-1273
pubmed: 26755159
Nat Methods. 2013 Feb;10(2):125-7
pubmed: 23263690
Biochem Soc Trans. 2015 Oct;43(5):966-74
pubmed: 26517911
Cell. 2016 Sep 8;166(6):1423-1435.e12
pubmed: 27594426
Pharmacol Ther. 2011 Feb;129(2):220-38
pubmed: 20951731
PLoS Pathog. 2015 Nov 06;11(11):e1005268
pubmed: 26544049
J Biol Chem. 2016 Apr 29;291(18):9566-80
pubmed: 26933036
EMBO J. 2012 Dec 12;31(24):4524-34
pubmed: 23149386
J Biol Chem. 1999 Mar 12;274(11):7272-7
pubmed: 10066789
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3278-87
pubmed: 23112171
PLoS Pathog. 2014 Jun 19;10(6):e1004197
pubmed: 24945436
PLoS Pathog. 2014 Jul 17;10(7):e1004263
pubmed: 25032958
PLoS One. 2012;7(2):e32843
pubmed: 22403603
Science. 2008 Feb 29;319(5867):1215-20
pubmed: 18218864
Exp Parasitol. 1982 Apr;53(2):179-88
pubmed: 6800836
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Nat Struct Mol Biol. 2010 May;17(5):596-601
pubmed: 20436473
PLoS Pathog. 2017 Mar 13;13(3):e1006272
pubmed: 28288194
Science. 2006 Dec 15;314(5806):1780-3
pubmed: 17170306
J Eukaryot Microbiol. 1996 Mar-Apr;43(2):120-7
pubmed: 8720941
PLoS Pathog. 2012;8(11):e1003049
pubmed: 23209419
Mol Microbiol. 1999 Jan;31(2):421-8
pubmed: 10027960
EMBO J. 2003 Mar 3;22(5):1005-13
pubmed: 12606566
mBio. 2014 May 13;5(3):e01114-14
pubmed: 24825012
J Cell Sci. 2004 Nov 15;117(Pt 24):5739-48
pubmed: 15507483
Cell Calcium. 2015 Mar;57(3):186-93
pubmed: 25605521
Science. 1993 Apr 16;260(5106):349-52
pubmed: 8469986
Anal Biochem. 2011 Aug 15;415(2):206-8
pubmed: 21575589
PLoS Pathog. 2011 Sep;7(9):e1002222
pubmed: 21980283
J Biol Chem. 2001 Nov 2;276(44):41492-501
pubmed: 11526113
PLoS Pathog. 2019 Feb 11;15(2):e1007577
pubmed: 30742695
J Cell Sci. 2003 Jul 15;116(Pt 14):3009-16
pubmed: 12783987
PLoS Pathog. 2012;8(12):e1003066
pubmed: 23226109
J Neurosci. 2011 Apr 27;31(17):6565-75
pubmed: 21525297
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Cell Host Microbe. 2009 Jun 18;5(6):612-22
pubmed: 19527888
Cell Host Microbe. 2012 Nov 15;12(5):682-92
pubmed: 23159057
ACS Chem Biol. 2013;8(6):1155-62
pubmed: 23530747
Anal Chem. 2003 Apr 15;75(8):1895-904
pubmed: 12713048
J Cell Biol. 2013 Aug 19;202(4):685-98
pubmed: 23940117
Exp Parasitol. 2017 May;176:52-58
pubmed: 28257757

Auteurs

Bethan A Wallbank (BA)

Signalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, UK.

Caia S Dominicus (CS)

Signalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, UK.

Malgorzata Broncel (M)

Signalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, UK.

Nathalie Legrave (N)

Metabolomics Science Technology Platform, The Francis Crick Institute, London, UK.

Gavin Kelly (G)

Bioinformatics and Biostatistics STP, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

James I MacRae (JI)

Metabolomics Science Technology Platform, The Francis Crick Institute, London, UK.

Henry M Staines (HM)

Institute of Infection and Immunity, St George's, University of London, London, UK.

Moritz Treeck (M)

Signalling in Apicomplexan Parasites Laboratory, The Francis Crick Institute, London, UK.

Articles similaires

Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female

Classifications MeSH